Dr. Tahseen Izhar, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 214 Ne 19th Drive, Okeechobee, FL 34972 Phone: 863-357-9677 Fax: 863-763-4509 |
News Archive
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Many U.S. children face a terrible burden of stressors that can harm the development of their brains and nervous systems. These stressors can lead to health problems and diseases throughout their lives, ultimately causing some to die prematurely, according to the lead author of a new study.
The Massachusetts State Legislature and Governor's Administration recently authorized into law a "Train Vets to Treat Vets" program for the Massachusetts School of Professional Psychology (MSPP)—in conjunction with the Massachusetts Department of Veterans Services—to establish a behavioral health career development program for returning veterans.
Emerson Ecologics, LLC announces an expanded partnership with Gaia Herbs Professional Solutions as one of their two select distributors. Effective May 1st, Gaia Herbs is asking all of its Professional Solutions customers to order products through a distributor. Gaia Herbs Professional Solutions will be sold through distribution in order to advance the company's commitment to sustainability practices and provide enhanced ordering benefits to their healthcare practitioner customers.
› Verified 4 days ago